Cancel

Grow Solutions

(No Reviews)
875 Pacific Hwy, Pymble NSW 2073, Australia

Grow Solutions is located in Ku-ring-gai Council of New South Wales state. On the street of Pacific Highway and street number is 875. To communicate or ask something with the place, the Phone number is (02) 9391 6000. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find Grow Solutions quickly are -33.7483244 ,151.1458738

Contact and Address

Address: 875 Pacific Hwy, Pymble NSW 2073, Australia
Postal code: 2073
Phone: (02) 9391 6000
Website: http://growsolutions.com.au/

Location & routing

Get Directions

Reviews

There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Grow Solutions, use the form below and your opinion, advice or comment will appear in this space.

Write a Review


Grow Solutions On the Web

Grow Solutions - Store | 875 Pacific Hwy, Pymble NSW 2073 ...

Grow Solutions is located in Ku-ring-gai Council of New South Wales state. On the street of Pacific Highway and street number is 875. To communicate or ask something with the place, the Phone number is (02) 9391 6000.


Farm Supplies in Sydney on Cylex - cylex-australia.com

Results for Farm Supplies in Sydney. Get free custom quotes, customer reviews ☆, prices, ☎ contact details , ⌚ opening hours from Sydney based businesses with Farm Supplies keyword.


Grow Solutions Review Ratings & Information

Checkout Grow Solutions Watch Video The Business Unit Animal Health at Bayer is a global leader in animal health. We support the health of animals, as well as the farmers, veterinarians and the pet owners that care for them through our offering of innovative therapies and solutions.


(D) NEOS THERAPEUTICS NASDAQ:NEOS - secure.fundsupermart.com

(D) NEOS THERAPEUTICS NASDAQ:NEOS - secure.fundsupermart.com


MEI Pharma Inc (NASDAQ : MEIP) | FSMOne

Company Profile. MEI Pharma Inc is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.